CryoFuture Company Profile

Background

CryoFuture, established on October 1, 2022, is a tech-enabled cryostorage facility headquartered in San Mateo, California. The company specializes in providing advanced cryostorage and transportation services for fertility clinics and patients across the United States. With a mission to revolutionize the field of cryostorage, CryoFuture integrates cutting-edge technology and stringent safety protocols to ensure the highest standards of specimen security and viability. The company's vision is to enhance the fertility journey for patients and clinics alike by offering innovative solutions that promote education and awareness about fertility preservation options.

Key Strategic Focus

CryoFuture's strategic focus encompasses:

Advanced Cryostorage Solutions: Offering state-of-the-art facilities equipped with disaster-resistant vaults and continuous monitoring systems to ensure specimen safety.

Secure Transportation Services: Providing GPS-enabled transport with real-time location tracking and temperature monitoring to maintain optimal conditions during specimen transfers.

Technological Integration: Implementing proprietary technologies such as RFID tracking systems and AI-driven inventory management to enhance operational efficiency and reduce human error.

Nationwide Expansion: Establishing a network of biorepositories across key regions, including San Francisco, Los Angeles, New Jersey/New York, Atlanta, Chicago, and Dallas, to offer localized services and strengthen regional transportation networks.

Financials and Funding

As a privately held company, specific financial details and funding history for CryoFuture are not publicly disclosed. However, the company's rapid expansion and technological advancements indicate a strong financial foundation and strategic investments in infrastructure and innovation.

Pipeline Development

CryoFuture's development pipeline focuses on expanding its network of cryostorage facilities and enhancing service offerings. In 2025, the company plans to open new facilities in Seattle, Washington, and Denver, Colorado, to further strengthen its presence in the Pacific Northwest and Mountain regions. These expansions aim to provide increased accessibility and support for fertility preservation services nationwide.

Technological Platform and Innovation

CryoFuture distinguishes itself through several proprietary technologies and innovative methodologies:

RFID Tracking System: Provides real-time, individual tracking for each specimen, ensuring precise location data and reducing human error.

CryoFuture Vision: An advanced visual monitoring system that allows for real-time inspections of canes and cryodevices, offering transparent verification and remote witnessing.

CryoFuture One™: An AI-driven inventory system that optimizes storage allocation, streamlines workflows, and enhances overall operational efficiency.

Secure Patient App: A user-friendly application that grants patients and clinics 24/7 access to specimen information, account management, and real-time updates.

These technologies are complemented by a five-point security protocol, disaster-resistant facilities, and continuous monitoring systems to ensure unparalleled protection for stored specimens.

Leadership Team

CryoFuture's leadership team comprises experienced professionals dedicated to advancing cryostorage technology:

Sean Pae: Founder and CEO, with over a decade of experience as an embryologist, leading the company's mission to revolutionize cryostorage solutions.

John Spears: Chief Commercial Officer, overseeing commercial strategies and partnerships.

James Watson: Chief Financial Officer, managing the company's financial operations.

Devin Monahan: Chief Innovation Officer, driving technological advancements and innovation.

Cherie Kloss: Chairman of the Board, providing strategic guidance and leadership.

David Burton: Chief Technology Officer, leading the development and implementation of technological solutions.

Tuan Bui: Board Member and Tissue Bank Medical Director, offering medical oversight and expertise.

The leadership team is supported by vice presidents and directors specializing in business development, client services, finance, and logistics, collectively bringing over 200 years of combined experience in embryology and related fields.

Leadership Changes

As of July 15, 2025, there have been no publicly announced significant changes or appointments within CryoFuture's leadership team.

Competitor Profile

Market Insights and Dynamics

The cryostorage and fertility preservation industry is experiencing significant growth, driven by increasing demand for assisted reproductive technologies and advancements in cryopreservation methods. The market is characterized by a focus on enhancing specimen security, improving transportation logistics, and integrating advanced technologies to meet the evolving needs of clinics and patients.

Competitor Analysis

Key competitors in the cryostorage and fertility preservation sector include:

Prelude Fertility: Offers a comprehensive network of fertility clinics and cryostorage services, focusing on personalized patient care and advanced reproductive technologies.

Route 92 Medical: Specializes in medical device innovations, including cryopreservation solutions, aiming to improve patient outcomes through technological advancements.

Trevarx Biomedical: Develops biomedical technologies with applications in cryostorage, emphasizing research-driven solutions for fertility preservation.

These competitors focus on integrating advanced technologies and expanding service offerings to meet the growing demand for secure and efficient cryostorage solutions.

Strategic Collaborations and Partnerships

CryoFuture has established significant partnerships to enhance its service capabilities:

Progyny: As an in-network tissue transportation provider for Progyny, CryoFuture offers seamless billing experiences and secure transportation services, ensuring peace of mind for patients during their fertility journey.

REI Insurance Solutions LLC: Collaborated to develop the Extra Protection Program (EPP), providing comprehensive insurance coverage for CryoFuture's facilities and storage tanks, setting a new industry standard for specimen security.

Operational Insights

CryoFuture's strategic considerations include:

Market Positioning: Establishing itself as a leader in cryostorage by integrating advanced technologies and expanding its nationwide network.

Competitive Advantages: Offering proprietary technologies, disaster-resistant facilities, and comprehensive insurance coverage to differentiate from competitors.

Service Excellence: Providing personalized customer service, transparent communication, and tailored protection plans to meet the unique needs of clinics and patients.

Strategic Opportunities and Future Directions

CryoFuture's strategic roadmap includes:

Facility Expansion: Opening new biorepositories in Seattle and Denver to enhance service accessibility and support.

Technological Innovation: Continuing to develop and integrate advanced technologies to improve specimen security, operational efficiency, and customer experience.

Partnership Development: Establishing additional collaborations with fertility clinics, healthcare providers, and technology partners to expand service offerings and market reach.

Educational Initiatives: Promoting awareness and education about fertility preservation options to empower patients and support informed decision-making.